0
Aimmune Therapeutics, Inc. Banner Image

Aimmune Therapeutics, Inc. has reached its limit for free report views

Work for Aimmune Therapeutics, Inc.? Upgrade Your Profile and unlock all your annual reports.

Aimmune Therapeutics, Inc.

  • Ticker AIMT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Aimmune Therapeutics, Inc. Logo Image
  • 201-500 Employees
  • Based in Brisbane, California
Aimmune Therapeutics, Inc. is a biopharmaceutical company that aspires to become the global leader in developing curative therapies and solutions for patients with food allergies. With a mission to improve the lives of people with food allergies, Aimmune is developing and commercializing oral treatments for potentially life-threatening food allergies. The Company’s Characterized Oral DesensitizationMore ImmunoTherapy (CODIT™) approach is intended to provide meaningful levels of protection against allergic reactions resulting from accidental exposure to food allergens by desensitizing patients with defined, precise amounts of key allergens. Aimmune has one FDA-approved medicine for peanut allergy and other investigational therapies in development to treat other food allergies.
Aimmune Therapeutics, Inc.

Most Recent Annual Report

Aimmune Therapeutics, Inc. MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Aimmune Therapeutics, Inc. has reached its limit for free report views.

Older/Archived Annual Reports